Portfolio company
Inscripta
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company provides a digital genome engineering platform for biotechnology, pharmaceutical and agricultural customers to perform automated CRISPR-based gene editing.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ginkgo Bioworks
This company develops biological platforms and cell programming technology for customers in the biopharma, agriculture, food, and materials industries.
JUMPCODE Genomics
This company develops CRISPR-based reagent kits that remove unwanted genetic sequences from sequencing libraries for researchers in oncology, infectious disease and basic research.
Toolgen
Toolgen develops genome editing technologies and therapeutic products for pharmaceutical and agricultural companies, providing gene editing tools and customized cell line services.
Genome Compiler
This company provides a software platform for genetic engineering and synthetic biology, allowing scientists to design, manage and order DNA sequences.
DNA Script
This company develops benchtop enzymatic DNA synthesis instruments for life science researchers and laboratories to produce synthetic nucleic acids on demand.
Tessera
The company develops genome engineering platforms to write therapeutic DNA sequences into cells for clinicians and researchers treating genetic diseases.
Twist Bioscience
This company manufactures synthetic DNA on silicon chips for customers in the drug discovery, diagnostics, agriculture, and academic research sectors.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
